Newsletter | January 2, 2026

01.02.26 -- 2025 Tariffs Barely Impact Europe's API Supply Chains

SPONSOR

INDUSTRY INSIGHTS

Technology Transfer: A Seamlessly Integrated Approach

From the digital infrastructure needed to enable a collaborative approach to the quality systems and analytical methods, effective tech transfer relies on consideration of a variety of factors.

Establishing And Safeguarding Shelf Life In Combination Products

Establishing shelf life requires aligning drug, device, and packaging stability to meet global standards, ensuring function, safety, and label claims across the supply chain.

How High Drug Load Nanocrystalline Tablets Lower Pill Burden

We showcase the development of high drug load nanocrystal based tablets and prove that nanocrystals can match the pharmacokinetic performance of ASDs while reducing the overall pill burden.

FEATURED EDITORIAL

2025 Tariffs Barely Impact Europe's API Supply Chains

When earlier this year the Trump administration began waving the specter of tariffs on drug substances and products entering the U.S., the biopharma world held its breath. European countries, as much as even China, felt the lack of oxygen. Would, for example, global sponsors leave European CDMOs to relocate their API production at contractors in the U.S.? Here's what we uncovered.

Key Elements Of Effective Tech Transfer Management

This segment of the Outsourced Pharma Live event, “Small Molecule Outsourcing: Getting Timelines, Tech Transfer and Analytics Right,” focuses on the key elements of a successful tech transfer for small molecule processes, emphasizing realistic expectations on duration, leveraging CDMO chemistry expertise to refine rather than simply copy the process, and treating the CDMO as an extension of the sponsor’s own team focused on long-term product quality. Featuring panelist Natalie Farris, Executive CMC Consultant at Naltou Pharma CMC Consulting, LLC.

INDUSTRY INSIGHTS CONTINUED

3D Screen Printing: Breakthrough Solutions For Patient-Centric Therapies

Explore 3D screen printing’s potential to revolutionize pharmaceutical manufacturing with scalable, customizable, multi-drug tablets and precise, patient-centric drug release profiles.

Unlock Robust And Reliable Stability Data With The Right Partner

Stability testing is essential to ensuring your drug’s stability, potency, efficacy, and safety under different controlled conditions throughout development, manufacturing, and life cycle management.

Form Fill And Seal Label Applicator For Drug Packaging

Discover an innovative solution that guarantees exceptionally efficient and reliable labeling for both vertical and horizontal form-fill seal machines.

Winning Strategies For Oral Dosage Form Development And Manufacturing

Failure to identify a compound’s red flags early in development often manifests as program delays or failures. Assimilate how to avoid these setbacks through complete molecular characterization.

SOLUTIONS

Solid Form Services

We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program.

Small Molecule: Development And Manufacturing

With over three decades of experience, Curia Small Molecule specializes in process chemistry, process safety, scale-up, and cGMP API manufacturing for preclinical, clinical, and commercial supply.

OUTSOURCED PHARMA CAPABILITIES UPDATE

Find Your New CDMO At Outsourced Pharma Capabilities Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: